Fundamentally different with orlistat, KY19334 suppress inflammation with the improvement of obesity by the Wisp1-mediated suppression of expression of the Pparγ and Cebpα9. The gene discussed is CCN4; the disease is obesity due to melanocortin 4 receptor deficiency.